Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Poll Archives

Are you getting vaccinated yourself?

  • Yes (0%)
  • No (100%)

Start Date: March 3, 2021 @ 12:41 pm
End Date: No Expiry

Are you recommending your patients get vaccinated?

  • Yes (0%)
  • No (100%)

Start Date: March 3, 2021 @ 12:36 pm
End Date: No Expiry

With the new guidelines for the use of hydroxychloroquine recommending a reduction of the daily dose from 6 to 5 mg/kg, do you anticipate lowering the daily dose for most of your patients?

  • B. No (51%)
  • A. Yes (49%)

Start Date: November 7, 2016 @ 2:07 pm
End Date: No Expiry

How do you view the imminent release of biosimilar therapies on the biologic marketplace?

  • B. They will have a substantial effect. (60%)
  • A. They will have a disruptive effect. (21%)
  • C. They will have little to no effect. (19%)

Start Date: October 6, 2016 @ 5:06 pm
End Date: No Expiry

Which of the following specialties do you interact with the most in your practice of rheumatology?

  • C. Orthopedics (39%)
  • A. Dermatology (30%)
  • E. Other specialty (22%)
  • B. Gastroenterology (6%)
  • D. Cardiology (3%)

Start Date: September 9, 2016 @ 4:09 pm
End Date: No Expiry

 Page 1 of 5  1  2  3  4  5  » 
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences